AAAAAA

   
Results: 1-13 |
Results: 13
CONCENTRATION OF ENDOGENOUS TPA ANTIGEN IN CORONARY-ARTERY DISEASE - RELATION TO THROMBOTIC EVENTS, ASPIRIN TREATMENT, HYPERLIPIDEMIA, AND MULTIVESSEL DISEASE
Authors: GEPPERT A GRAF S BECKMANN R HORNYKEWYCZ S SCHUSTER E BINDER BR HUBER K
Citation: A. Geppert et al., CONCENTRATION OF ENDOGENOUS TPA ANTIGEN IN CORONARY-ARTERY DISEASE - RELATION TO THROMBOTIC EVENTS, ASPIRIN TREATMENT, HYPERLIPIDEMIA, AND MULTIVESSEL DISEASE, Arteriosclerosis, thrombosis, and vascular biology, 18(10), 1998, pp. 1634-1642
RESTORATION OF CORONARY BLOOD-FLOW BY SINGLE BOLUS INJECTION OF THE GPIIB IIIA RECEPTOR ANTAGONIST C7E3 FAB IN A PATIENT WITH ACUTE MYOCARDIAL-INFARCTION OF RECENT-ONSET/
Authors: DOMANOVITS H NIKFARDJAM M JANATA K HORNYKEWYCZ S MAURER G LAGGNER AN HUBER K
Citation: H. Domanovits et al., RESTORATION OF CORONARY BLOOD-FLOW BY SINGLE BOLUS INJECTION OF THE GPIIB IIIA RECEPTOR ANTAGONIST C7E3 FAB IN A PATIENT WITH ACUTE MYOCARDIAL-INFARCTION OF RECENT-ONSET/, Clinical cardiology, 21(7), 1998, pp. 525-528
BIOCHEMICAL MONITORING OF DOUBLE-BOLUS VERSUS FRONT-LOADED THROMBOLYTIC THERAPY WITH ALTEPLASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
Authors: ZASMETA G ZEINER A HORNYKEWYCZ S BECKMANN R ZORN G DOMANOVITS H SCHREIBER W LAGGNER AN BINDER BR HUBER K
Citation: G. Zasmeta et al., BIOCHEMICAL MONITORING OF DOUBLE-BOLUS VERSUS FRONT-LOADED THROMBOLYTIC THERAPY WITH ALTEPLASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Thrombosis and haemostasis, 1997, pp. 2054-2054
EVALUATION OF BEDSIDE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASUREMENT BY COAGULATION ANALYZER COAGUCHEK PLUS(R) IN VARIOUS CLINICAL SETTINGS
Authors: RUZICKA K KAPIOTIS S QUEHENBERGER P HANDLER S HORNYKEWYCZ S MICHITSCH A HUBER K CLEMENS D SUSAN M PABINGER I EICHINGER S JILMA B SPEISER W
Citation: K. Ruzicka et al., EVALUATION OF BEDSIDE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASUREMENT BY COAGULATION ANALYZER COAGUCHEK PLUS(R) IN VARIOUS CLINICAL SETTINGS, Thrombosis research, 87(5), 1997, pp. 431-440
IS OXIDATIVE STRESS CAUSALLY LINKED TO UNSTABLE ANGINA-PECTORIS - A STUDY IN 100 CAD PATIENTS AND MATCHED CONTROLS
Authors: KOSTNER K HORNYKEWYCZ S YANG P NEUNTEUFL T GLOGAR D WEIDINGER F MAURER G HUBER K
Citation: K. Kostner et al., IS OXIDATIVE STRESS CAUSALLY LINKED TO UNSTABLE ANGINA-PECTORIS - A STUDY IN 100 CAD PATIENTS AND MATCHED CONTROLS, Cardiovascular Research, 36(3), 1997, pp. 330-336
LABORATORY MONITORING OF THROMBOLYTIC THERAPY WITH 2 DIFFERENT DOSE REGIMEN OF RT-PA IN ACUTE MYOCARDIAL-INFARCTION - PEAK T-PA PLASMA-LEVELS ARE NOT RELATED WITH SUCCESS OF THERAPY
Authors: HUBER K ZEINER A BECKMANN R HORNYKEWYCZ S LAGGNER AN BINDER BR
Citation: K. Huber et al., LABORATORY MONITORING OF THROMBOLYTIC THERAPY WITH 2 DIFFERENT DOSE REGIMEN OF RT-PA IN ACUTE MYOCARDIAL-INFARCTION - PEAK T-PA PLASMA-LEVELS ARE NOT RELATED WITH SUCCESS OF THERAPY, Thrombosis and haemostasis, 73(6), 1995, pp. 1327-1327
ANTIHYPERTENSIVE THERAPY AND CORONARY-ART ERY DISEASE - THE ROLE OF INFLUENCING COEXISTING CARDIOVASCULAR RISK-FACTORS
Authors: HUBER K WEIN W HORNYKEWYCZ S ZEHETGRUBER M RAUSCHA F
Citation: K. Huber et al., ANTIHYPERTENSIVE THERAPY AND CORONARY-ART ERY DISEASE - THE ROLE OF INFLUENCING COEXISTING CARDIOVASCULAR RISK-FACTORS, Acta medica austriaca, 22(3), 1995, pp. 48-51
LABORATORY MONITORING OF SUCCESS AND FAILURE OF THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION
Authors: HUBER K HORNYKEWYCZ S GRAF S GABRIEL H GEPPERT A
Citation: K. Huber et al., LABORATORY MONITORING OF SUCCESS AND FAILURE OF THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION, Fibrinolysis, 9, 1995, pp. 53-57
TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN PATIENTS WITH CORONARY-ARTERY DISEASE - RELATIONS TO CLINICAL-VARIABLES AND CARDIOVASCULAR RISK-FACTORS
Authors: GEPPERT A BECKMANN R GRAF S HORNYKEWYCZ S LANG I SCHUSTER E BINDER BR HUBER K
Citation: A. Geppert et al., TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN PATIENTS WITH CORONARY-ARTERY DISEASE - RELATIONS TO CLINICAL-VARIABLES AND CARDIOVASCULAR RISK-FACTORS, Fibrinolysis, 9, 1995, pp. 109-113
RISK ASSESSMENT AND SECONDARY PREVENTION IN ANGINA-PECTORIS AND FOLLOWING MYOCARDIAL-INFARCTION
Authors: HUBER K HORNYKEWYCZ S ANGLESCANO E
Citation: K. Huber et al., RISK ASSESSMENT AND SECONDARY PREVENTION IN ANGINA-PECTORIS AND FOLLOWING MYOCARDIAL-INFARCTION, Der Internist, 36(9), 1995, pp. 883-890
BIOCHEMICAL MARKERS OF MYOCARDIAL NECROSIS IN ACUTE MYOCARDIAL-INFARCTION AND THROMBOLYSIS
Authors: HORNYKEWYCZ S GABRIEL H HUBER K
Citation: S. Hornykewycz et al., BIOCHEMICAL MARKERS OF MYOCARDIAL NECROSIS IN ACUTE MYOCARDIAL-INFARCTION AND THROMBOLYSIS, Annals of hematology, 69(4), 1994, pp. 190000059-190000063
TISSUE-TYPE PLASMINOGEN-ACTIVATOR (TPA) LEVELS IN PATIENTS WITH CORONARY-ARTERY DISEASE (CAD) - CORRELATION WITH CLINICAL SEVERITY AND MEDICAL THERAPY
Authors: GEPPERT A BECKMANN R GRAF S HORNYKEWYCZ S BINDER BR HUBER K
Citation: A. Geppert et al., TISSUE-TYPE PLASMINOGEN-ACTIVATOR (TPA) LEVELS IN PATIENTS WITH CORONARY-ARTERY DISEASE (CAD) - CORRELATION WITH CLINICAL SEVERITY AND MEDICAL THERAPY, Circulation, 90(4), 1994, pp. 553-553
TISSUE-TYPE PLASMINOGEN-ACTIVATOR (TPA) LEVELS IN PATIENTS WITH CORONARY-ARTERY DISEASE (CAD) - CORRELATION WITH CLINICAL SEVERITY AND MEDICAL THERAPY
Authors: GEPPERT A BECKMANN R GRAF S HORNYKEWYCZ S BINDER BR HUBER K
Citation: A. Geppert et al., TISSUE-TYPE PLASMINOGEN-ACTIVATOR (TPA) LEVELS IN PATIENTS WITH CORONARY-ARTERY DISEASE (CAD) - CORRELATION WITH CLINICAL SEVERITY AND MEDICAL THERAPY, Circulation, 90(4), 1994, pp. 553-553
Risultati: 1-13 |